Thrombocytosis as a poor prognostic factor in ovarian cancer

被引：0
|
作者：
Jorgensen, T. [1 ]
Teiblum, S. T. [2 ]
Paludan, M. [3 ]
Poulsen, L. O. [4 ]
Jorgensen, A. Y. S. [5 ]
Bruun, K. H. [6 ]
Herrstedt, J. [1 ,7 ]
机构：
[1] Odense Univ Hosp, DK-5000 Odense, Denmark
[2] Herlev Hosp, Copenhagen, Denmark
[3] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[4] Aalborg Univ Hosp, Aalborg, Denmark
[5] Naestved Hosp, Naestved, Denmark
[6] Univ Copenhagen Hosp, DK-2100 Copenhagen, Denmark
[7] Univ Southern Denmark, Odense, Denmark
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3019
引用
收藏
页码：S718 / S718
页数：1
相关论文
共 50 条
  • [31] Thrombocytosis as a prognostic factor in endometrial carcinoma
    Gucer, F
    Moser, F
    Tamussino, K
    Reich, O
    Haas, J
    Arikan, G
    Petru, E
    Winter, R
    [J]. GYNECOLOGIC ONCOLOGY, 1998, 70 (02) : 210 - 214
  • [32] Overexpression of EGFR Is a Poor Prognostic Indicator in Ovarian Cancer
    Djordjevic, B.
    Rosea, D. G.
    Liu, J.
    [J]. MODERN PATHOLOGY, 2009, 22 : 212A - 212A
  • [33] Old age as a poor prognostic factor in epithelial ovarian cancer: What is the best age cutoff?
    Kim, W. Y.
    Kim, J.
    Song, T.
    Jeong, S. Y.
    Paik, E. S.
    Lee, Y. Y.
    Choi, C. H.
    Kim, T. J.
    Lee, J. W.
    Kim, B. G.
    Bae, D. S.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 108 - 109
  • [34] Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival
    Cohen, J.
    Tran, A.
    Rimel, B. J.
    Cass, I.
    Walsh, C.
    Karlan, B.
    Li, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 270 - 270
  • [35] Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma
    Sano, Rikiya
    Kanomata, Naoki
    Suzuki, Soichiro
    Shimoya, Koichiro
    Sato, Yasufumi
    Moriya, Takuya
    Shiota, Mitsuru
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 243 (02): : 107 - 114
  • [36] NIS Mediates Iodide Uptake in the Female Reproductive Tract and Is a Poor Prognostic Factor in Ovarian Cancer
    Riesco-Eizaguirre, Garcilaso
    Garcia Leoni, Suzana
    Mendiola, Marta
    Angeles Estevez-Cebrero, Maria
    Ines Gallego, Marta
    Redondo, Andres
    Hardisson, David
    Santisteban, Pilar
    De la Vieja, Antonio
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (07): : E1199 - E1208
  • [37] Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival
    Cohen, Joshua G.
    Arthur-Quan Tran
    Rimel, B. J.
    Cass, Ilana
    Walsh, Christine S.
    Karlan, Beth Y.
    Li, Andrew J.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 556 - 559
  • [38] Is race a poor prognostic factor in breast cancer?
    El-Tamer, MB
    Homel, P
    Wait, RB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (01) : 41 - 45
  • [39] Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group
    Canzler, Ulrich
    Lueck, Hans-Joachim
    Neuser, Petra
    Sehouli, Jalid
    Burges, Alexander
    Harter, Philipp
    Schmalfeldt, Barbara
    Aminossadati, Behnaz
    Mahner, Sven
    Kommoss, Stefan
    Wimberger, Pauline
    Pfisterer, Jacobus
    de Gregorio, Nikolaus
    Hasenburg, Annette
    Gropp-Meier, Martina
    El-Balat, Ahmed
    Jackisch, Christian
    du Bois, Andreas
    Meier, Werner
    Wagner, Uwe
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (05) : 1267 - 1274
  • [40] Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group
    Ulrich Canzler
    Hans-Joachim Lück
    Petra Neuser
    Jalid Sehouli
    Alexander Burges
    Philipp Harter
    Barbara Schmalfeldt
    Behnaz Aminossadati
    Sven Mahner
    Stefan Kommoss
    Pauline Wimberger
    Jacobus Pfisterer
    Nikolaus de Gregorio
    Annette Hasenburg
    Martina Gropp-Meier
    Ahmed El-Balat
    Christian Jackisch
    Andreas du Bois
    Werner Meier
    Uwe Wagner
    [J]. Archives of Gynecology and Obstetrics, 2020, 301 : 1267 - 1274
12345